Literature DB >> 32175387

A two-circular RNA signature of donor circFOXN2 and circNECTIN3 predicts early allograft dysfunction after liver transplantation.

Kun Wang1,2, Xuyong Wei1,2, Qiang Wei1,2, Di Lu1,2, Wangyao Li1,2, Binhua Pan1,2, Junli Chen3, Haiyang Xie1,2, Shusen Zheng1,2,4, Xiao Xu1,2.   

Abstract

BACKGROUND: Early allograft dysfunction (EAD) following liver transplantation is associated with poor recipient and graft survival. In recent years, circular RNAs (circRNAs) have emerged as important components of endogenous RNAs. This study aims to explore the expression profile and predictive value of graft circular RNAs for EAD after liver transplantation.
METHODS: RNA sequencing was conducted to identify the circRNA profile in donor liver tissues. Furthermore, quantitative real-time polymerase chain reaction (qRT-PCR) was used to identify candidate circRNAs. A novel model combining circular RNA signature was established to predict EAD based on the multivariate analysis.
RESULTS: A total of 442 circRNAs were differentially expressed between the EAD and non-EAD groups, of which, 223 were significantly upregulated and 219 were downregulated in the EAD group (Fold change >2, P<0.05). qRT-PCR validation indicated that circFOXN2 and circNECTIN3 levels in the EAD group were significantly lower than those in the non-EAD group (P=0.038, 0.024, respectively; n=115). Among the 115 recipients, 32 recipients with high circFOXN2 expression were classified as circular RNA signature A and the rest recipients with low circFOXN2 expression were categorized into circular RNA signature B (n=33, high circNECTIN3 expression) and C (n=50, low circNECTIN3 expression). The incidence rates of EAD in signature A, B and C were significantly different (3.1%, 21.2% and 42.0%, respectively; P=0.000). According to the multivariate analysis, a novel predictive model for EAD was developed based on CIT (P=0.000) and circular RNA signature (P=0.013). The novel model displayed a high predictive value for EAD with areas under the curve (AUC) of 0.870 (95% CI: 0.797-0.942).
CONCLUSIONS: Donor circFOXN2 and circNEXTIN3 were associated with the incidence of EAD. The novel model combing the two-circular RNA signature had a high predictive value for EAD. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Circular RNA; early allograft dysfunction (EAD); liver transplantation

Year:  2020        PMID: 32175387      PMCID: PMC7049052          DOI: 10.21037/atm.2019.12.132

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  30 in total

1.  Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.

Authors:  Kim M Olthoff; Laura Kulik; Benjamin Samstein; Mary Kaminski; Michael Abecassis; Jean Emond; Abraham Shaked; Jason D Christie
Journal:  Liver Transpl       Date:  2010-08       Impact factor: 5.799

2.  Genomic profiles and predictors of early allograft dysfunction after human liver transplantation.

Authors:  S M Kurian; S M G Fouraschen; P Langfelder; S Horvath; A Shaked; D R Salomon; K M Olthoff
Journal:  Am J Transplant       Date:  2015-03-31       Impact factor: 8.086

3.  Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.

Authors:  Dieter P Hoyer; Andreas Paul; Anja Gallinat; Ernesto P Molmenti; Renate Reinhardt; Thomas Minor; Fuat H Saner; Ali Canbay; Jürgen W Treckmann; Georgios C Sotiropoulos; Zoltan Mathé
Journal:  Liver Int       Date:  2014-01-24       Impact factor: 5.828

4.  A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor II.

Authors:  Lan Li; Guogang Li; Chaohui Yu; Zhe Shen; Chengfu Xu; Zhiying Feng; Xuequn Zhang; Youming Li
Journal:  Liver Int       Date:  2014-01-09       Impact factor: 5.828

5.  Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.

Authors:  Hae Won Lee; Gi-Won Song; Sung-Gyu Lee; Jong Man Kim; Jae-Won Joh; Dai Hoon Han; Soon Il Kim; Seong Hoon Kim; Dong-Sik Kim; Jai Young Cho; Kyung-Suk Suh
Journal:  Liver Transpl       Date:  2018-09       Impact factor: 5.799

6.  Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.

Authors:  Dan Han; Jiangxue Li; Huamin Wang; Xiaoping Su; Jin Hou; Yan Gu; Cheng Qian; Yun Lin; Xiang Liu; Mingyan Huang; Nan Li; Weiping Zhou; Yizhi Yu; Xuetao Cao
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

7.  MiR-27a-5p regulates apoptosis of liver ischemia-reperfusion injury in mice by targeting Bach1.

Authors:  Yu Xing; Jing Li; Shi-Peng Li; Jiri Xi; Ning Ma; Lei Liu; Jin-Shan Wang; Jin-Zhen Cai
Journal:  J Cell Biochem       Date:  2018-08-26       Impact factor: 4.429

8.  Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.

Authors:  Jian Yu; Qing-Guo Xu; Zhen-Guang Wang; Yuan Yang; Ling Zhang; Jin-Zhao Ma; Shu-Han Sun; Fu Yang; Wei-Ping Zhou
Journal:  J Hepatol       Date:  2018-01-31       Impact factor: 25.083

Review 9.  Circles reshaping the RNA world: from waste to treasure.

Authors:  Jing Liu; Tian Liu; Xiaman Wang; Aili He
Journal:  Mol Cancer       Date:  2017-03-09       Impact factor: 27.401

10.  A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.

Authors:  Xiao-Xia Liu; Yi-E Yang; Xiao Liu; Meng-Yu Zhang; Rui Li; Yun-Hong Yin; Yi-Qing Qu
Journal:  J Transl Med       Date:  2019-02-18       Impact factor: 5.531

View more
  3 in total

Review 1.  Past, Present and Future: The Relationship Between Circular RNA and Immunity.

Authors:  Junjie Gu; Chongying Su; Fei Huang; Yuwei Zhao; Jing Li
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

2.  Combination of Early Allograft Dysfunction and Protein Expression Patterns Predicts Outcome of Liver Transplantation From Donation After Cardiac Death.

Authors:  Qiang Wei; Junbin Zhou; Kun Wang; Xuanyu Zhang; Junli Chen; Di Lu; Xuyong Wei; Shusen Zheng; Xiao Xu
Journal:  Front Med (Lausanne)       Date:  2021-12-08

3.  Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma.

Authors:  Binhua Pan; Modan Yang; Xuyong Wei; Wangyao Li; Kun Wang; Mengfan Yang; Di Lu; Rui Wang; Beini Cen; Xiao Xu
Journal:  Aging (Albany NY)       Date:  2021-07-19       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.